|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0026848,
umls-concept:C0030705,
umls-concept:C0032113,
umls-concept:C0032952,
umls-concept:C0074512,
umls-concept:C0205269,
umls-concept:C0302350,
umls-concept:C0332281,
umls-concept:C0332283,
umls-concept:C0393022,
umls-concept:C0679199,
umls-concept:C1706089
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-5-8
|
|
pubmed:abstractText |
We report two patients with myopathy associated with anti-signal recognition particle Ab, refractory to conventional therapy, who were treated with prednisone and plasma exchange, followed by rituximab. A marked response was observed in both patients, with partial to complete recovery of muscle strength, which was sustained.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0960-8966
|
|
pubmed:author |
pubmed-author:ArletJean-BenoitJB,
pubmed-author:AtassiMarielleM,
pubmed-author:AuthierFrançois-JéromeFJ,
pubmed-author:BenvenisteOlivierO,
pubmed-author:Bloch-QueyratCoralieC,
pubmed-author:BoyerOlivierO,
pubmed-author:DimitriDaliaD,
pubmed-author:GoulvestreClaireC,
pubmed-author:GuillevinLoïcL,
pubmed-author:HersonSergeS,
pubmed-author:HeshmatiFarhadF,
pubmed-author:MaisonobeThierryT,
pubmed-author:MouthonLucL,
pubmed-author:PagnouxChristianC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
334-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16616848-Adult,
pubmed-meshheading:16616848-Anti-Inflammatory Agents,
pubmed-meshheading:16616848-Antibodies, Monoclonal,
pubmed-meshheading:16616848-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:16616848-Antibody Formation,
pubmed-meshheading:16616848-Autoantibodies,
pubmed-meshheading:16616848-B-Lymphocytes,
pubmed-meshheading:16616848-Clinical Protocols,
pubmed-meshheading:16616848-Disease Progression,
pubmed-meshheading:16616848-Female,
pubmed-meshheading:16616848-Humans,
pubmed-meshheading:16616848-Immunologic Factors,
pubmed-meshheading:16616848-Male,
pubmed-meshheading:16616848-Muscle, Skeletal,
pubmed-meshheading:16616848-Muscular Diseases,
pubmed-meshheading:16616848-Plasma Exchange,
pubmed-meshheading:16616848-Prednisone,
pubmed-meshheading:16616848-Signal Recognition Particle,
pubmed-meshheading:16616848-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
|
|
pubmed:affiliation |
Department of Internal Medicine, Faculty of Medicine, Cochin Hospital, Paris-Descartes University, Assistance Publique-Hôpitaux de Paris, AP-HP, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
